Send to

Choose Destination
J Clin Hypertens (Greenwich). 2017 Feb;19(2):116-125. doi: 10.1111/jch.12942. Epub 2016 Nov 14.

Baseline blood pressure control in Hispanics: characteristics of Hispanics in the Systolic Blood Pressure Intervention Trial.

Author information

Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Department of Internal Medicine - Cardiovascular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Division of Nephrology and Hypertension, Clinical Hypertension Program, University Hospitals Case Medical Center, Cleveland, OH, USA.
Department of Biostatistics, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Department of Internal Medicine, NEON Health Centers, Cleveland, OH, USA.
Department of Internal Medicine, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX, USA.
Department of Medicine - Nephrology, Stanford University, Stanford, CA, USA.
Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH, USA.
Department of Nephrology, University of Illinois at Chicago, Chicago, IL, USA.
Division of Cardiovascular Disease, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Department of Medicine, Punzi Medical Center, Carrollton, TX, USA.
Department of Pharmacology, Veterans Affairs Medical Center, Albuquerque, NM, USA.
Memphis Veterans Affairs Medical Center, Memphis, TN, USA.
Department of Nephrology - Internal Medicine, University of Miami, Miami, FL, USA.
Department of Medicine - Nephrology, Veterans Affairs Medical Center, Albuquerque, NM, USA.
Department of Internal Medicine - Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA.


The Systolic Blood Pressure Intervention Trial (SPRINT) tested whether a systolic blood pressure (SBP) value <120 mm Hg reduces adverse clinical outcomes compared with the goal of <140 mm Hg. Here the authors describe the baseline characteristics of Hispanic participants in SPRINT. Nondiabetic hypertensive patients 50 years and older with SBP 130-180 mm Hg taking zero to four blood pressure (BP) medications were enrolled from the mainland United States and Puerto Rico. Cross-sectional, bivariate analysis was employed comparing sociodemographic and clinical factors in Hispanics vs non-Hispanics. Multivariable logistic regression models restricted to Hispanics were used to identify factors associated with achieved BP control (SBP <140 mm Hg and diastolic BP <90 mm Hg) at baseline. Eleven percent (n=984) of SPRINT participants were Hispanic; 56% (n=549) of Hispanics were living in Puerto Rico and the remainder were living on the US mainland. Hispanics overall were younger, more often female, less likely to live alone, and more likely to have lower education and be uninsured, although just as likely to be employed compared with non-Hispanics. BP control was not different between Hispanics vs non-Hispanics at baseline. However, a significantly higher percentage of Hispanics on the US mainland (compared with Hispanics in Puerto Rico) had controlled BP. BP control was independently associated with cardiovascular disease history and functional status among Hispanics, specifically those living in Puerto Rico, whereas functional status was the only independent predictor of BP control identified among mainland Hispanics. These findings highlight the diversity of the SPRINT population. It remains to be seen whether factors identified among Hispanics impact intervention goals and subsequent clinical outcomes.


Hispanics; blood pressure; clinical trials

[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substance, Grant support

Publication types

MeSH terms


Grant support

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center